Quoin Pharmaceuticals Ltd.
QNRX | NASDAQ
$6.90
-$0.16 (-2.27%)
At close: Sep 21, 2026, 4:00 PM ET
$6.90
$0 (0.00%)
Pre-market:
Sep 22, 2026, 6:06 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -15.81B | -15.81B | -15.8B | -13.77M | -12.17M | -10.45M | -8.96M | -8.7M | -8.28M | -8.39M | -8.66M | -8.61M | -9.72M | -10.3M | -9.39M | -19.2M | -17.58M | -19.25M | -21.47M | -10.67M | -9.59M | -5.6M |
Depreciation & Amortization | 100M | 100M | 100M | 100K | 100K | 100K | 100K | 100.67K | 101.68K | 102.38K | 103.39K | 103.73K | 103.73K | 104.04K | 104.1K | 104.1K | 78.09K | 78.09K | 78.03K | 78.03K | 104.04K | 104.04K |
Stock-Based Compensation | 1.15B | 1.15B | 1.15B | 1.19M | 1.32M | 1.68M | 1.63M | 1.6M | 1.56M | 1.14M | 1.09M | 1.06M | 1.06M | 1.03M | 763.72K | 496.44K | 229.44K | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 1.28M | 557.06K | 811.29K | 880.22K | -256.35K | -69.2K | -278.09K | -81.5K | -295.12K | -56.4K | 45.15K | 48.42K | 617.81K | 437.54K | 213.97K | 74.35K | 111.15K | 331K | 453.98K | 1.04M | 266.64K | 64.13K |
Other Non-Cash Items | 14.54B | 14.54B | 14.54B | 180.25K | -366.11K | -956.48K | -343.95K | -1.76M | -1.36M | -530.51K | -624.6K | 706.41K | 555.69K | 391.91K | -553.81K | 7.48M | 7.9M | 11.06M | 14.59M | 6.7M | 6.57M | 3.52M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 2.09M | 97.34K | 1.23M | 1.55M | 418.33K | 605.48K | -278.09K | -81.5K | -8.91K | 403.9K | 505.45K | 439.4K | 722.58K | 646.91K | 585.82K | 1.4M | 1.81M | 1.48M | 1.85M | 1.57M | 480.85K | 547.47K |
Operating Cash Flow | -15.39M | -15.86M | -13.59M | -10.74M | -10.7M | -9.02M | -7.86M | -8.84M | -7.99M | -7.54M | -7.85M | -6.57M | -7.54M | -8.13M | -8.49M | -9.72M | -7.57M | -6.64M | -4.95M | -2.32M | -2.43M | -1.43M |
Capital Expenditures | 1 | 4 | 4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -200K | -200K | -450K | -450K | -375K | -517.5K | -267.5K | -267.5K | -142.5K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -12.27B | -12.27B | -12.26B | n/a | n/a | n/a | n/a | n/a | -4.6M | -4.59M | -4.59M | -4.59M | 9.8K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 18.62B | 18.62B | 18.62B | 7.16M | 4.63M | 2.94M | n/a | n/a | 4.6M | 7.6M | 7.6M | 7.6M | 3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -6.36B | -6.36B | -6.36B | -3.35M | -750.47K | 2.4M | -1.89M | 3.93M | 1.33M | -1.82M | -847.51K | -3.49M | -13.39M | -13.39M | -9.9M | -9.9M | n/a | n/a | n/a | -125K | -125K | -125K |
Investing Cash Flow | -610.32K | -3.01M | -4.36M | 3.81M | 3.88M | 5.35M | -1.89M | 3.93M | 1.33M | 1.19M | 2.16M | -483.76K | -10.38M | -13.59M | -10.15M | -10.4M | -874.72K | -799.72K | -892.12K | -767.12K | -392.5K | -267.5K |
Debt Repayment | -150K | -300K | -450K | -600K | -600K | -600K | -600K | -600K | -725K | -575K | -525K | -686.67K | -561.67K | -561.67K | -461.67K | -150K | 3.47M | 5.54M | 6.95M | 7.86M | 4.38M | 2.32M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -453.45K | -300.97K | -150.63K | 6.07M | 6.07M | 6.09M | 11.57M | 5.46M | 5.48M | 5.39M | 5.76M | 5.65M | 20.54M | 20.47M | 14.47M | 24.86M | 9.96M | 10.03M | 10.08M | -95.15K | 158.09K | 454.63K |
Financial Cash Flow | 18.19M | 18.19M | 18.16M | 5.64M | 5.64M | 5.66M | 10.97M | 4.86M | 4.74M | 4.8M | 5.21M | 4.95M | 19.98M | 19.91M | 14.01M | 24.71M | 13.23M | 15.37M | 16.83M | 7.56M | 4.54M | 2.77M |
Net Cash Flow | 2.18M | -697.66K | 194.69K | -1.29M | -1.18M | 1.99M | 1.22M | -46.68K | -1.91M | -1.54M | -459.51K | -2.09M | 2.07M | -1.82M | -4.62M | 4.6M | 13.56K | 3.16M | 6.21M | -301.06K | 1.72M | 1.08M |
Free Cash Flow | -15.39M | -15.86M | -13.59M | -10.74M | -10.7M | -9.02M | -7.86M | -8.84M | -7.99M | -7.54M | -7.85M | -6.57M | -7.54M | -8.33M | -8.69M | -10.17M | -8.02M | -7.01M | -5.47M | -2.58M | -2.7M | -1.57M |
Adj. Free Cash Flow | -1.16B | -1.16B | -1.16B | -11.93M | -12.02M | -10.7M | -9.48M | -10.45M | -9.54M | -8.67M | -8.94M | -7.63M | -8.6M | -9.36M | -9.45M | -10.67M | -8.25M | -7.01M | -5.47M | -2.58M | -2.7M | -1.57M |
Maintenance CapEx | -7 | -4 | -4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -26.01K | -26.01K | -52.02K | -52.02K | -52.02K | -78.03K | -52.02K | -52.02K | -26.01K |
Growth CapEx | 8 | 8 | 8 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -173.99K | -173.99K | -397.97K | -397.98K | -322.98K | -439.47K | -215.48K | -215.48K | -116.49K |
Owner Earnings | -15.39M | -15.86M | -13.59M | -10.74M | -10.7M | -9.02M | -7.86M | -8.84M | -7.99M | -7.54M | -7.85M | -6.57M | -7.54M | -8.16M | -8.51M | -9.77M | -7.62M | -6.69M | -5.03M | -2.37M | -2.48M | -1.46M |
Add to Watchlist
Select watchlists to add or remove QNRX